Dr. Dinter obtained broad experience in research and development of pharmaceutical agents while working in biotech and large pharma companies in Germany and the USA. During 2014- 2018, Dr. Dinter was the Sr. Vice President (SVP) and Head of Biologics, Drug Discovery, Bayer Pharma AG, where he was responsible for global research and development of biologics at Bayer. From 2007 to 2011, Dr. Dinter was the Sr. Vice President and Head of Operation of Global Drug Discovery of Bayer HealthCare and he was Vice President of Berlex Biosciences (2006). Dr. Dinter holds a Ph.D. in Biochemistry and Biotechnology, and completed the Business Management Program from Harvard Business School as well as the course on Management of Technology and Innovation from Caltech. Throughout his career he led various research groups and departments in pharma and biotech. Development of strategies and their successful implementation as well as evaluation of projects and making clear decisions on these are among Dr. Dinter’s core competencies. Since 2018, Dr. Dinter advises companies and research institutes on the definition and focusing of their strategy and during acquisitions as well as licensing of technologies.